Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 7/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 6/20 | 0.34 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.34 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.30 |
| ▸ | HSP90AB1 | P08238 | 2/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10813404 | 0.89 | HDAC1 (0.36) | HDAC1HDAC6HDAC4HDAC2HDAC8 | |
| SCHEMBL10816708 | 0.79 | CDK2 (0.37) | — | |
| SCHEMBL10816323 | 0.75 | HDAC6 (0.42) | HDAC1HDAC6HDAC4HDAC2SMN1; SMN2 | |
| SCHEMBL10813561 | 0.73 | YTHDC1 (0.46) | NPC1 | |
| SCHEMBL10812769 | 0.72 | MAPT (0.35) | HDAC1HDAC6HDAC4HDAC2HDAC8 | |
| SCHEMBL10813415 | 0.71 | PDE3A (0.46) | HDAC1HDAC6HDAC4HDAC2SMN1; SMN2 | |
| SCHEMBL10818088 | 0.71 | CDC20 (0.35) | HDAC1HDAC2HDAC8HSP90AA1HSP90AB1 | |
| SCHEMBL9583170 | 0.70 | CDK1 (0.47) | HDAC1HDAC2HDAC8HSP90AA1HSP90AB1 | |
| SCHEMBL10814393 | 0.69 | HK1 (0.39) | HDAC1HDAC2HDAC8NPC1RAB9A | |
| SCHEMBL10812288 | 0.69 | CDK1 (0.40) | HDAC1HDAC2HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0105135-B1 | SUBSTITUTED 9-(1-0- OR 3-0-MONOSUBSTITUTED OR 1,3-DI-0-SUBSTITUTED 1,3 DIHYDROXY-2-PROPOXYMETHYL) PURINES AS ANTIVIRAL AGENTS | SYNTEX (U.S.A.) INC. (US) | 1987-03-18 | — | — | EP | disclosed |
| US-4609661-A | HERPES VIRUS | SYNTEX (U.S.A.) INC. (US) | 1986-09-02 | — | — | US | disclosed |
| US-4556659-A | Substituted 9-(1-0- or 3-0-monosubstituted or 1,3-Di-0-substituted propoxymethyl)-purines as antiviral agents | SYNTEX (U.S.A.) INC. (US) | 1985-12-03 | — | — | US | disclosed |
| EP-0105135-A1 | Substituted 9-(1-0- or 3-0-monosubstituted or 1,3-di-0-substituted 1,3 dihydroxy-2-propoxymethyl) purines as antiviral agents | SYNTEX (U.S.A.) INC. (US) | 1984-04-11 | — | — | EP | disclosed |